Product Information
GUANFACINE 2 MG TABLET is a generic product labeled by i3 Pharmaceuticals, LLC, priced at $0.2673 per EA under NDC 72319001904. Its NADAC has been published 130 times since Apr 10, 2024.
FDA first approved this application on Oct 5, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
i3 Pharmaceuticals, LLCNDC
72319001904
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUANFACINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216828FDA Approved
10/5/2023
TE Code
AB
On Market Since
10/31/2022
Pharmacological Classes
Price Statistics
The NADAC for GUANFACINE 2 MG TABLET has been published 130 times since Apr 10, 2024, and over the history we have for it it has declined 35.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2673 per EA |
|---|---|
| All-time high | $0.4552 (Jul 10, 2024) |
| All-time low | $0.2410 (Feb 18, 2026) |
| 52-week high | $0.3037 |
| 52-week low | $0.2410 |
| Median price | $0.3037 |
| Average price | $0.3104 |
| Largest weekly change | +61.2% (Aug 21, 2024) |
| Weeks tracked | 130 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Gaunfacine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
i3 Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Gaunfacine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central alpha-2 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GUANFACINE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GUANFACINE 2 MG TABLET, manufactured by i3 Pharmaceuticals, LLC, is $0.2673 per EA (NDC 72319001904), effective Sep 30, 2026.
How has the price of GUANFACINE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for GUANFACINE 2 MG TABLET has declined 35.1%. It has been tracked across 130 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for GUANFACINE 2 MG TABLET?
Since Apr 10, 2024, the NADAC for GUANFACINE 2 MG TABLET has ranged from a low of $0.2410 (Feb 18, 2026) to a high of $0.4552 (Jul 10, 2024), with a median of $0.3037 per EA.
Are there cheaper alternatives to GUANFACINE 2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of GUANFACINE 2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GUANFACINE 2 MG TABLET?
GUANFACINE 2 MG TABLET (NDC 72319001904) is labeled by i3 Pharmaceuticals, LLC, and CMS classifies it as a generic product.